J. E. Karp

482 citations

14 papers · 411 indexed · h-index 9

Hematology top 5%
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 2
Genetics top 10%
- Chronic Lymphocytic Leukemia Research 2
Oncology
- Neutropenia and Cancer Infections 5
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 2
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 3
Clinical Biochemistry
- Bacterial Identification and Susceptibility Testing 1
Biomedical Engineering
- Biomedical and Engineering Education 1

Co-authors: P. J. Burke Samuel Broder Ross C. Donehower Steven Piantadosi Curt I. Civin Marianna Zahurak Robert B. Geller Craig A. Hurwitz
Cited by: Hematology Genetics Oncology
Journals: British Journal of Haematology (1 paper)Journal of Clinical Oncology (1 paper)Leukemia Research (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

J. E. Karp

14 papers receiving 386 citations

Peers

Countries citing papers authored by J. E. Karp

Since Specialization

Citations

This map shows the geographic impact of J. E. Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. E. Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. E. Karp more than expected).

Fields of papers citing papers by J. E. Karp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. E. Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. E. Karp. The network helps show where J. E. Karp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. E. Karp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. E. Karp Line = papers co-authored together J. E. Karp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS) Journal of Clinical Oncology ·Frank Giles,Stephen J. O’Brien,Norbert Vey,E. Feldman,David A. Rizzieri,Khuda Dad Khan,Hugo Maurico Ovalle Arciniegas,Somayeh Valiyan,G J Mufti,Barry C. Johnson,J. E. Karp	2005	3
2	Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia: impact of induction Ara-C dose and post-remission therapy Leukemia Research ·Eduardo M. Sotomayor,Steven Piantadosi,Carole B. Miller,J. E. Karp,Richard J. Jones,Scott D. Rowley,Scott H. Kaufmann,HG Braine,Philip J. Burke,Steven D. Gore	2002	11
3	Management of infections in neutropenic patients: Advances in therapy and prevention J. E. Karp,William G. Merz,James D. Dick	1993	2
4	Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas. PubMed ·J. E. Karp,Samuel Broder	1991	67
5	Training in clinical research in oncology. PubMed ·Brian W. Kimes,А. А. Кулаков,Khoa Nguyen,J. E. Karp,S. S. Yang	1991	6
6	Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10) British Journal of Haematology ·Robert B. Geller,Marianna Zahurak,Craig A. Hurwitz,Correa Asanza Katherine,J. E. Karp,Steven Piantadosi,Curt I. Civin	1990	151
7	Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients. PubMed ·Chris Billinghurst,Ethan Goldiez,J. E. Karp,Joan Selverstone Valentine	1988	19
8	Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA Arthritis & Rheumatism ·Ronenn Roubenoff,Richard J. Jones,J. E. Karp,T. Russell Woolley	1987	20
9	Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion. PubMed ·Ross C. Donehower,J. E. Karp,P. J. Burke	1986	83
10	The relationship between humoral stimulating activity and colony stimulating factor. PubMed ·J. E. Karp,Richard K. Shadduck,Philip J. Burke,J H Shaper	1983	8
11	The correlation of maximal drug dose, tumor recruitment, and sequence timing with therapeutic advantage: Schedule-dependent toxicity of cytosine arabinoside Medical and Pediatric Oncology ·P. J. Burke,William P. Vaughan,J. E. Karp,Fitrotul Chasanah	1982	9
12	Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts. PubMed ·Zineb Bajaddoub,A. W. Kimball,J. E. Karp,G Mussgnug,P. J. Burke	1982	25
13	Analysis of factors related to bone marrow graft rejection in aplastic anemia: usefulness of measures of broad alloimmunity as predictors. PubMed ·Gerald J. Elfenbein,Chris Marshall,H. Braine,WB Bias,P. J. Tutschka,J. E. Karp,PJ Burke,Moody D. Wharam,Rein Saral,Herbert Kaizer,Mellits Ed,G. Santos	1981	5
14	Effective chemotherapy of acute myelocytic leukemia (AML) occurring after alkylating agent therapy (AAT) or radiation therapy (RT) for prior malignancy William P. Vaughan,J. E. Karp,P. J. Burke	1981	2

About J. E. Karp

J. E. Karp is a scholar working on Hematology, Genetics, Oncology, Molecular Medicine and Microbiology, having authored 14 papers that have together received 411 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Neutropenia and Cancer Infections (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Bacterial Identification and Susceptibility Testing (1 paper) and Biomedical and Engineering Education (1 paper). The work is most often cited by research in Hematology (222 citations), Genetics (85 citations), Oncology (143 citations), Pathology and Forensic Medicine (79 citations) and Public Health, Environmental and Occupational Health (97 citations). J. E. Karp has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include P. J. Burke, Samuel Broder, Ross C. Donehower, Steven Piantadosi, Curt I. Civin, Marianna Zahurak, Robert B. Geller, Craig A. Hurwitz, Richard J. Jones and Joan Selverstone Valentine. Their work appears in journals such as British Journal of Haematology, Journal of Clinical Oncology, Leukemia Research, Arthritis & Rheumatism and Medical and Pediatric Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact